10 Vaccines in human clinical trial stage
124 Projects globally in hunt of Covid-19 vaccine
20 Projects in India at pre-clinical stage
By Winter. This is the ambitious target set by scientists to defeat Covid-19.
Regulators, scientists and life sciences companies are working at break-neck speed in what has become the largest and fastest vaccine/drug hunt in human history.
Biotech specialists are using all available platforms or vehicles – dead, artificially engineered and live viruses, apart from DNA- or RNA-based ones – to transport virus-killing antigens into human cells. Big pharmaceutical companies such as Pfizer, Novartis and GlaxoSmithKline are collaborating with each other. They have also opened their patented libraries of drug knowledge to researchers and academia. Governments and philanthropists are pumping in billions of dollars into promising projects. Scientists are attempting hundreds of treatment options from novel plasma and antigen injections to reusing old molecules right from Made in India anti-malarial hydroxychloroquine to HIV anti-virals to psoriasis or hepatitis drugs.
Normally, it takes four-six years to launch a vaccine right from developing a candidate and animal trials to three-stage human trials. The time to bring a drug to market is ten years. Scientists screen lakhs of chemical compounds, identify the candidate and develop it for two-three years before starting clinical trials. Only one or two out of ten candidates reach the human clinical trials stage.
Bu hikaye Business Today dergisinin June 28, 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Today dergisinin June 28, 2020 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Pension Scheme - Safety Net
The move to introduce the UPS has evoked mixed reactions. Analysts believe its funding will have limited impact on the fiscal math
The Reit Choice?
Real Estate Investment Trusts (Reits) Are Gaining Traction As Interest Rates Stabilise. But Returns Could Be Affected By Adverse Economic Conditions And Market Volatility
CORPORATE - Calling to Account
The sudden exit of Byju's auditor BDO marks the latest in a long series of setbacks for the edtech firm
EMPLOYMENT: Skills Push
The skill development ministry plans to partner with the UGC to improve the employability of undergraduates
Building on a Vision
L&T'S CHAIRMAN EMERITUS A. M. NAIK HAS BUILT A MAMMOTH ENTERPRISE THAT IS BUILDING A NEW INDIA, FROM ITS METRO RAIL SYSTEMS TO THE RAM TEMPLE
"KYS more important than KYC"
Vijay Kedia is a renowned equity investor; the value of his listed portfolio stands at around ₹1,750 crore
ROXX STAR
THE THAR ROXX COMBINES LUXURY WITH PERFORMANCE TO MAKE A STRONG STATEMENT IN THE MID-SIZE SUV SEGMENT
HIT THE GROUND RUNNING
Smartwatches have become indispensable tools for runners, offering real-time insights into pace, distance, heart rate, and more. Here are a few you can consider
TURNING THE TABLES
INDIA'S FURNITURE MARKET IS POISED FOR A GLOBAL TAKE-OFF. ALREADY, A HOST OF GLOBAL BRANDS HAVE MADE THE COUNTRY THEIR HOME, BUT INDIAN COMPANIES ARE NOT TOO FAR BEHIND
THE EVOLUTION OF ATHERA
IDENTIFYING OPPORTUNITIES IN ADVANCE HAS STOOD THIS BENGALURU-BASED VC FUND IN GOOD STEAD. NOW, WITH A HEIGHTENED FOCUS ON TECHNOLOGY, IT WANTS TO SUSTAIN THE SUCCESS